ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,565 | -33.7% | 13,659 | +0.4% | 0.00% | – |
| Q2 2023 | $141,094 | +42.6% | 13,606 | +11.3% | 0.00% | – |
| Q1 2023 | $98,925 | -54.6% | 12,228 | -11.6% | 0.00% | -100.0% |
| Q4 2022 | $217,791 | +8.4% | 13,828 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $201,000 | +20.4% | 12,730 | +6.9% | 0.00% | 0.0% |
| Q2 2022 | $167,000 | -39.1% | 11,907 | -25.1% | 0.00% | 0.0% |
| Q1 2022 | $274,000 | -4.5% | 15,905 | -19.5% | 0.00% | 0.0% |
| Q4 2021 | $287,000 | +44.9% | 19,760 | +75.4% | 0.00% | 0.0% |
| Q2 2021 | $198,000 | +1137.5% | 11,264 | -23.4% | 0.00% | – |
| Q3 2019 | $16,000 | -54.3% | 14,710 | -6.9% | 0.00% | – |
| Q2 2019 | $35,000 | -67.0% | 15,798 | -11.0% | 0.00% | -100.0% |
| Q1 2019 | $106,000 | -18.5% | 17,755 | +0.8% | 0.00% | 0.0% |
| Q4 2018 | $130,000 | -43.7% | 17,607 | +10.7% | 0.00% | -50.0% |
| Q3 2018 | $231,000 | -30.0% | 15,903 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $330,000 | +9.3% | 16,510 | -4.2% | 0.00% | 0.0% |
| Q1 2018 | $302,000 | -39.0% | 17,228 | -14.1% | 0.00% | -33.3% |
| Q4 2017 | $495,000 | – | 20,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |